Benu BioPharma is a biopharmaceutical development management and consulting company. Benu BioPharma is focused on providing the essential functional expertise for drug development with the efficiency, nimbleness and speed that is critical to success for an entrepreneurial organization. The company is based in Natick, Massachusetts.
Benu is a unique venture model based on active partnership of experienced drug developers. Benu takes an asset-based approach where each new product-focused company becomes an individual investment. We believe that academic and biotechnology centers in Boston and southern New England are great engines for novel, product focused technologies around which we build our companies. Benu benefits from decades of experience utilizing the virtual company model and builds upon existing projects, both of which received funding in 2012.
2012-2015 Virtual biotechnology companies managed by Benu BioPharma
LipimetiX Development, LLC -Apolipoprotein E mimetic peptide for Homozygous Familial Hypercholesterolemia (HoFH), coronary artery and peripheral artery diseases in preclinical development. The lead peptide was extensively validated in the most relevant animal models by a leading academic institution prior to formation of the company. >> Visit LipimetiX Development
eXIthera Pharmaceuticals, Inc - An early stage biotech company focused on developing small molecule pharmaceuticals to inhibit Factor Xla, an important enzyme in the blood coagulation pathway. The novel drugs being developed by eXIthera, unlike all presently approved anticoagulants/antithrombotics, are expected to prevent thrombosis without causing bleeding. >> Visit eXIthera Pharmaceuticals
Topical Remedy, LLC
-Novel topical drug formulation for the treatment of herpes labialis, suitable for the OTC market. Topical Remedy is currently in Phase 2 clinical trials.